- Home
- BGLC vs JNVR Comparison
BGLC vs JNVR Comparison
Compare BGLC & JNVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGLC
- JNVR
- Stock Information
- Founded
- BGLC 2017
- JNVR 2018
- Country
- BGLC Malaysia
- JNVR United States
- Employees
- BGLC N/A
- JNVR N/A
- Industry
- BGLC Medical Specialities
- JNVR Finance: Consumer Services
- Sector
- BGLC Health Care
- JNVR Finance
- Exchange
- BGLC Nasdaq
- JNVR Nasdaq
- Market Cap
- BGLC 5.8M
- JNVR 5.4M
- IPO Year
- BGLC N/A
- JNVR 2023
- Fundamental
- Price
- BGLC $0.25
- JNVR $4.90
- Analyst Decision
- BGLC
- JNVR
- Analyst Count
- BGLC 0
- JNVR 0
- Target Price
- BGLC N/A
- JNVR N/A
- AVG Volume (30 Days)
- BGLC 1.5M
- JNVR 17.2K
- Earning Date
- BGLC 05-14-2025
- JNVR 03-13-2025
- Dividend Yield
- BGLC N/A
- JNVR N/A
- EPS Growth
- BGLC N/A
- JNVR N/A
- EPS
- BGLC N/A
- JNVR N/A
- Revenue
- BGLC $9,259,858.00
- JNVR $2,099,660.00
- Revenue This Year
- BGLC N/A
- JNVR N/A
- Revenue Next Year
- BGLC N/A
- JNVR N/A
- P/E Ratio
- BGLC N/A
- JNVR N/A
- Revenue Growth
- BGLC N/A
- JNVR 4.82
- 52 Week Low
- BGLC $0.21
- JNVR $3.37
- 52 Week High
- BGLC $1.00
- JNVR $10.64
- Technical
- Relative Strength Index (RSI)
- BGLC 35.57
- JNVR 53.17
- Support Level
- BGLC $0.23
- JNVR $4.45
- Resistance Level
- BGLC $0.29
- JNVR $6.46
- Average True Range (ATR)
- BGLC 0.02
- JNVR 0.79
- MACD
- BGLC -0.01
- JNVR 0.08
- Stochastic Oscillator
- BGLC 20.22
- JNVR 37.85
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.
About JNVR Janover Inc.
Janover Inc is a B2B fintech marketplace providing a platform for commercial property borrowers and lenders. It provides a technology platform that connects commercial mortgage borrowers looking for debt to refinance, build, or buy commercial property including apartment buildings to commercial property lenders including banks, credit unions, REITs, debt funds, and more looking to deploy capital into commercial mortgages. The firm caters to two consumer segments: lenders and borrowers. It derives the majority of its revenue from transaction fees.